Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors

[1] Flechner SM(1999)Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial Transplantation 68 391-396

[2] Goldfarb D(2002)Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine Transplantation 74 1070-3220

[3] Modlin C(2001)The role of CerticanTM (everolimus, RAD) in the many pathways of chronic rejection Transpl Proc 33 3215-84

[4] Feng J(2001)Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation 72 1920-180

[5] Krishnamurthi V(2003)The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients Transplantation 76 1729-2836

[6] Mastroianni B(1996)Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin Transpl 10 77-2447

[7] Nashan B(2000)Sirolimus and cyclosporin for renal transplantation Lancet 356 179-780

[8] Humar A(1991)Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts Transpl Proc 23 2833-42

[9] Ramcharan T(2000)Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 605-302

[10] Denny R(2003)Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation Am J Transpl 3 1128-undefined

[1] Flechner SM(1999)Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial Transplantation 68 391-396

[2] Goldfarb D(2002)Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine Transplantation 74 1070-3220

[3] Modlin C(2001)The role of CerticanTM (everolimus, RAD) in the many pathways of chronic rejection Transpl Proc 33 3215-84

[4] Feng J(2001)Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation 72 1920-180

[5] Krishnamurthi V(2003)The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients Transplantation 76 1729-2836

[6] Mastroianni B(1996)Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin Transpl 10 77-2447

[7] Nashan B(2000)Sirolimus and cyclosporin for renal transplantation Lancet 356 179-780

[8] Humar A(1991)Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts Transpl Proc 23 2833-42

[9] Ramcharan T(2000)Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 605-302

[10] Denny R(2003)Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation Am J Transpl 3 1128-undefined